Literature DB >> 7811057

Multiple drug effect analysis with confidence interval.

M S Belen'kii1, R F Schinazi.   

Abstract

The development of mathematical models for determining antagonism, synergy or additivism for drug combinations is becoming increasingly important in medical research and medicine. This paper describes improvements in the Chou and Talalay method which provides for the first time confidence intervals for the combination index. The Monte Carlo technique was used to calculate the confidence intervals and to obtain the new parameters which are needed for the modified interaction diagnosis. This new method can be adapted to current as well as future formulae used to evaluate drug combinations. Programs written in Microsoft and Visual Basic were developed for use on commonly available personal computers which we call Combostat.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7811057     DOI: 10.1016/0166-3542(94)90089-2

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  22 in total

1.  Ribonucleoside analogue that blocks replication of bovine viral diarrhea and hepatitis C viruses in culture.

Authors:  Lieven J Stuyver; Tony Whitaker; Tamara R McBrayer; Brenda I Hernandez-Santiago; Stefania Lostia; Phillip M Tharnish; Mangala Ramesh; Chung K Chu; Robert Jordan; Junxing Shi; Suguna Rachakonda; Kyoichi A Watanabe; Michael J Otto; Raymond F Schinazi
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

2.  An experiment on standardized cell culture assay in assessing the activities of Composite Artemisia Capillaris Tablets against hepatitis B virus replication in vitro.

Authors:  Jin Han; Yan-ling Zhao; Li-mei Shan; Feng-jiao Huang; Xiao-he Xiao
Journal:  Chin J Integr Med       Date:  2005-03       Impact factor: 1.978

3.  Antiviral and cellular metabolism interactions between Dexelvucitabine and lamivudine.

Authors:  Brenda I Hernandez-Santiago; Judy S Mathew; Kim L Rapp; Jason P Grier; Raymond F Schinazi
Journal:  Antimicrob Agents Chemother       Date:  2007-04-02       Impact factor: 5.191

4.  Synthesis and anti-HIV-1 screening of novel N'-(1-(aryl)ethylidene)-2-(5,5-dioxido-3-phenylbenzo[e]pyrazolo[4,3-c][1,2]thiazin-4(1H)-yl)acetohydrazides.

Authors:  Sana Aslam; Matloob Ahmad; Muhammad Zia-Ur-Rehman; Catherine Montero; Mervi Detorio; Masood Parvez; Raymond F Schinazi
Journal:  Arch Pharm Res       Date:  2013-07-10       Impact factor: 4.946

5.  Confidence Intervals of Interaction Index for Assessing Multiple Drug Interaction.

Authors:  J Jack Lee; Maiying Kong
Journal:  Stat Biopharm Res       Date:  2009-02-01       Impact factor: 1.452

6.  Modeling combinations of antiretroviral agents in vitro with integration of pharmacokinetics: guidance in regimen choice for clinical trial evaluation.

Authors:  G L Drusano; M Prichard; P A Bilello; J A Bilello
Journal:  Antimicrob Agents Chemother       Date:  1996-05       Impact factor: 5.191

7.  In vitro combination of PNU-140690, a human immunodeficiency virus type 1 protease inhibitor, with ritonavir against ritonavir-sensitive and -resistant clinical isolates.

Authors:  K T Chong; P J Pagano
Journal:  Antimicrob Agents Chemother       Date:  1997-11       Impact factor: 5.191

8.  Synthesis and anti-HIV activity of D- and L-thietanose nucleosides.

Authors:  Hyunah Choo; Xin Chen; Vikas Yadav; Jianing Wang; Raymond F Schinazi; Chung K Chu
Journal:  J Med Chem       Date:  2006-03-09       Impact factor: 7.446

9.  Combinations of 2'-C-methylcytidine analogues with interferon-alpha2b and triple combination with ribavirin in the hepatitis C virus replicon system.

Authors:  Leda Bassit; Jason Grier; Matthew Bennett; Raymond F Schinazi
Journal:  Antivir Chem Chemother       Date:  2008

10.  Alpha interferon augments cidofovir's antiviral and antiproliferative activities.

Authors:  Jeffrey A Johnson; J David Gangemi
Journal:  Antimicrob Agents Chemother       Date:  2003-06       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.